CD47 and metastatic malignant neoplasm in the lymph nodes: Fourth, this retrospective study is unable to directly link MET and CD47 co-expression in primary tumors to the occurrence of hematogenous metastasis in luminal-type breast cancer patients (only to lymph node metastasis) due to the fact that initially only patients without distant metastases were included in our cohort and that we were unable to systematically obtain detailed information on the subsequent development of metastasis in these patients.